Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Go back to the Working Group on Thrombosis landing page
The most important aim of the Working Group on Thrombosis Young Researchers is to facilitate international networking, thereby strengthening the opportunities for international collaboration. The group is embedded in the ESC Working Group on Thrombosis and creates a strong organisational framework for young researchers interested in thrombosis. Another key aim is to provide member benefits, including grants, mentoring opportunities and international thrombosis meetings.
Please fill-in the online form by clicking the Join Now button.
Please note that you will be requested to login via your My ESC account first. If you are not yet registered on the ESC website, please sign-up.
JOIN NOWUnsuitable applicants (as far as formal requirements are concerned) may be rejected by the chairperson. In this case, the applicant will be notified but there is no obligation to give him/her the reasons.
Different Grants are provided by the ESC Working Group on Thrombosis for members of Young Researchers Group.
This is a Grant to enable attendance to the Eurothrombosis Meetings.
This is a Grant to recognise scientific work presented by young people at the Eurothrombosis Meetings
Visit your Working Group Meeting page to know more about it and submit your abstract.
This is a research Grant to be performed in a Center (clinical or basic) in order to facilitate scientific exchange and collaboration during one year.
In 2014, 2 young researchers have been selected and received a grant of 25.000 € each for their outstanding projects. Read below their testimonials:
"I am a PhD-Student at the Medical University of Vienna, Austria, in the research group of Prof. Johann Wojta and, with the Lab Exchange Grant from the ESC Working Group on Thrombosis, I will be able to work at the University of Uppsala, Sweden, under the supervision of Prof. Agneta Siegbahn. Agneta Siegbahn is one of the leading scientists in the field of thrombosis and tissue factor signalling. This grant enables the two research groups to collaborate in the field of atherothrombosis and facilitates the exchange of knowledge and experience between them.This project will help to elucidate the impact of the proinflammatory cytokine IL-33 on the coagulation capacity of human whole blood and will give insight into the molecular mechanisms of this process. By investigating tissue factor activity in monocytes subsets and monocyte-derived microparticles, the project aims to further clarify the interplay of inflammation and thrombosis in vascular disease". Dr Stefan Stojkovic
"I am a PhD-student working at Herning Regional Hospital, Denmark, enrolled at Aarhus University and supervised by Associate Professor Steen Husted, one of Europe’s leading experts in thrombocardiology. The grant will allow us to collaborate with the coagulation laboratory at Erasmus Medical Center in Rotterdam, the Netherlands, led by Associate Professor Moniek de Maat, a leading scientist in the field of coagulation analyses and anti-thrombotic therapy. My research stay in Rotterdam is of great importance for my PhD-project and for future scientific cooperation between the institutions involved.Our study focuses on adherence and the role of coagulation assays in patients treated with dabigatran etexilate for non-valvular atrial fibrillation". Dr Willemijn Comuth
© 2017 European Society of Cardiology. All rights reserved